Oligopeptide complex for targeted non-viral gene delivery to adipocytes (original) (raw)

• Rosen, E. D. & Spiegelman, B. M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444, 847–853 (2006).
  Article CAS Google Scholar
• Ouchi, N., Parker, J. L., Lugus, J. J. & Walsh, K. Adipokines in inflammation and metabolic disease. Nature Rev. Immunol. 11, 85–97 (2011).
  Article CAS Google Scholar
• Cinti, S. The adipose organ. Prostaglandins Leukot. Essent. Fatty Acids 73, 9–15 (2005).
  Article CAS Google Scholar
• Elangbam, C. S. Review paper: Current strategies in the development of anti-obesity drugs and their safety concerns. Vet. Pathol. 46, 10–24 (2009).
  Article CAS Google Scholar
• Schaffler, A., Scholmerich, J. & Salzberger, B. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol. 28, 393–399 (2007).
  Article CAS Google Scholar
• Ahima, R. S. Central actions of adipocyte hormones. Trends Endocrinol. Metab. 16, 307–313 (2005).
  Article CAS Google Scholar
• Cooke, D. & Bloom, S. The obesity pipeline: Current strategies in the development of anti-obesity drugs. Nature Rev. Drug Discov. 5, 919–931 (2006).
  Article CAS Google Scholar
• Nawrocki, A. R. & Scherer, P. E. Keynote review: The adipocyte as a drug discovery target. Drug Discov. Today 10, 1219–1230 (2005).
  Article CAS Google Scholar
• Stenkula, K. G. et al. Human, but not rat, IRS1 targets to the plasma membrane in both human and rat adipocytes. Biochem. Biophys. Res. Commun. 363, 840–845 (2007).
  Article CAS Google Scholar
• Watanabe, M. et al. Regulation of PPAR gamma transcriptional activity in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 300, 429–436 (2003).
  Article CAS Google Scholar
• Cao, L. et al. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nature Med. 15, 447–454 (2009).
  Article CAS Google Scholar
• Dhillon, H. et al. Central leptin gene therapy suppresses body weight gain, adiposity and serum insulin without affecting food consumption in normal rats: A long-term study. Regul. Pept. 99, 69–77 (2001).
  Article CAS Google Scholar
• Chen, G. et al. Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc. Natl Acad. Sci. USA 93, 14795–14799 (1996).
  Article CAS Google Scholar
• Won, Y. W., Yoon, S. M., Lee, K. M. & Kim, Y. H. Poly(oligo-D-arginine) with internal disulfide linkages as a cytoplasm-sensitive carrier for siRNA delivery. Mol. Ther. 19, 372–380 (2011).
  Article CAS Google Scholar
• Won, Y. W., Kim, H. A., Lee, M. & Kim, Y. H. Reducible poly(oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection. Mol. Ther. 18, 734–742 (2010).
  Article CAS Google Scholar
• Wilson, D. S. et al. Orally delivered thioketal nanoparticles loaded with TNF-alpha-siRNA target inflammation and inhibit gene expression in the intestines. Nature Mater. 9, 923–928 (2010).
  Article CAS Google Scholar
• Mok, H., Lee, S. H., Park, J. W. & Park, T. G. Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nature Mater. 9, 272–278 (2010).
  Article CAS Google Scholar
• Jeong, J. H., Kim, S. H., Christensen, L. V., Feijen, J. & Kim, S. W. Reducible poly(amido ethylenimine)-based gene delivery system for improved nucleus trafficking of plasmid DNA. Bioconjug. Chem. 21, 296–301 (2010).
  Article CAS Google Scholar
• Hyun, H. et al. Therapeutic effects of a reducible poly (oligo-D-arginine) carrier with the heme oxygenase-1 gene in the treatment of hypoxic-ischemic brain injury. Biomaterials 31, 9128–9134 (2010).
  Article CAS Google Scholar
• Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R. & Arap, W. Reversal of obesity by targeted ablation of adipose tissue. Nature Med. 10, 625–632 (2004).
  Article CAS Google Scholar
• Mishra, S., Murphy, L. C., Nyomba, B. L. & Murphy, L. J. Prohibitin: A potential target for new therapeutics. Trends Mol. Med. 11, 192–197 (2005).
  Article CAS Google Scholar
• Patel, N. et al. Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells. Proc. Natl Acad. Sci. USA 107, 2503–2508 (2010).
  Article CAS Google Scholar
• Sharma, A. & Qadri, A. Vi polysaccharide of Salmonella typhi targets the prohibitin family of molecules in intestinal epithelial cells and suppresses early inflammatory responses. Proc. Natl Acad. Sci. USA 101, 17492–17497 (2004).
  Article CAS Google Scholar
• Kim, T. I., Ou, M., Lee, M. & Kim, S. W. Arginine-grafted bioreducible poly(disulfide amine) for gene delivery systems. Biomaterials 30, 658–664 (2009).
  Article CAS Google Scholar
• Kumar, P. et al. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134, 577–586 (2008).
  Article CAS Google Scholar
• Furuhashi, M. & Hotamisligil, G. S. Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nature Rev. Drug Discov. 7, 489–503 (2008).
  Article CAS Google Scholar
• Wang, P. et al. Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell. Mol. Life Sci. 61, 2405–2417 (2004).
  CAS Google Scholar
• Veiseh, O. et al. Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. Biomaterials 32, 5717–5725 (2011).
  Article CAS Google Scholar
• Ter-Avetisyan, G. et al. Cell entry of arginine-rich peptides is independent of endocytosis. J. Biol. Chem. 284, 3370–3378 (2009).
  Article CAS Google Scholar
• Vazquez, E., Ferrer-Miralles, N. & Villaverde, A. Peptide-assisted traffic engineering for nonviral gene therapy. Drug Discov. Today 13, 1067–1074 (2008).
  Article CAS Google Scholar
• Uysal, K. T., Scheja, L., Wiesbrock, S. M., Bonner-Weir, S. & Hotamisligil, G. S. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141, 3388–3396 (2000).
  Article CAS Google Scholar